Literature DB >> 20386455

Dendritic cell-mediated HIV-1 infection of T cells demonstrates a direct relationship to plasma viral RNA levels.

Reetakshi Arora1, Lara Bull, Edward B Siwak, Rajesh Thippeshappa, Roberto C Arduino, Jason T Kimata.   

Abstract

OBJECTIVE: To examine the relationship between infectivity of HIV-1 variants in dendritic cell (DC)-mediated in trans infection of T cells and plasma viral RNA levels in infected subjects.
METHODS: HIV-1 was isolated from peripheral blood mononuclear cells of chronically infected individuals, typed for coreceptor usage, and viral replication were examined in monocyte-derived DCs-peripheral blood lymphocytes cocultures. The rate of p24 antigen production during the logarithmic phase of viral replication was determined by enzyme-linked immunosorbent assay. Additionally, nef variants were cloned and expressed in trans with a HIV luciferase vector and CCR5-tropic HIV-1 envelope, and infectivity was measured in DC-mediated capture-transfer assays.
RESULTS: Replication capacity of HIV-1 viral CCR5-tropic isolates in monocyte-derived dendritic cells-peripheral blood lymphocytes cocultures was linearly associated with the plasma viral RNA levels in a cohort of HIV-1-infected individuals exhibiting an inverse relationship between plasma viral RNA and CD4 cell count. Furthermore, infectivity activity of nef variants in context of DC-mediated enhanced infection of T cells also showed a linear relationship to plasma viral RNA levels.
CONCLUSIONS: These results illustrate that replication capacity of HIV-1 in DC T-cell cultures is a significant determinant of plasma viral RNA level. The data suggest that adaptation of HIV-1 to DC interactions with T cells influences the level of viral replication in the host.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20386455      PMCID: PMC3086406          DOI: 10.1097/QAI.0b013e3181daaf98

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.731


  42 in total

Review 1.  Host determinants in HIV infection and disease. Part 2: genetic factors and implications for antiretroviral therapeutics.

Authors:  C M Hogan; S M Hammer
Journal:  Ann Intern Med       Date:  2001-05-15       Impact factor: 25.391

2.  Recruitment of HIV and its receptors to dendritic cell-T cell junctions.

Authors:  David McDonald; Li Wu; Stacy M Bohks; Vineet N KewalRamani; Derya Unutmaz; Thomas J Hope
Journal:  Science       Date:  2003-05-01       Impact factor: 47.728

Review 3.  Practical applications of viral fitness in clinical practice.

Authors:  Michael Bates; Terri Wrin; Wei Huang; Christos Petropoulos; Nicholas Hellmann
Journal:  Curr Opin Infect Dis       Date:  2003-02       Impact factor: 4.915

4.  The increased replicative capacity of a late-stage simian immunodeficiency virus mne variant is evident in macrophage- or dendritic cell-T-cell cocultures.

Authors:  Jason T Kimata; Joelle M Wilson; Parul G Patel
Journal:  Virology       Date:  2004-10-01       Impact factor: 3.616

5.  Human immunodeficiency virus type 1 Nef incorporation into virions does not increase infectivity.

Authors:  Nadine Laguette; Serge Benichou; Stéphane Basmaciogullari
Journal:  J Virol       Date:  2008-11-05       Impact factor: 5.103

6.  Capture and transfer of simian immunodeficiency virus by macaque dendritic cells is enhanced by DC-SIGN.

Authors:  Monica T Yu Kimata; Marina Cella; Julia E Biggins; Colin Rorex; Robert White; Sarah Hicks; Joelle M Wilson; Parul G Patel; Jonathan S Allan; Marco Colonna; Jason T Kimata
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

7.  HIV type 1 variants transmitted to women in Kenya require the CCR5 coreceptor for entry, regardless of the genetic complexity of the infecting virus.

Authors:  E Michelle Long; Stephanie M J Rainwater; Ludo Lavreys; Kishorchandra Mandaliya; Julie Overbaugh
Journal:  AIDS Res Hum Retroviruses       Date:  2002-05-20       Impact factor: 2.205

8.  DC-SIGN interactions with human immunodeficiency virus type 1 and 2 and simian immunodeficiency virus.

Authors:  S Pöhlmann; F Baribaud; B Lee; G J Leslie; M D Sanchez; K Hiebenthal-Millow; J Münch; F Kirchhoff; R W Doms
Journal:  J Virol       Date:  2001-05       Impact factor: 5.103

9.  Highly pathogenic simian immunodeficiency virus mne variants that emerge during the course of infection evolve enhanced infectivity and the ability to downregulate CD4 but not class I major histocompatibility complex antigens.

Authors:  Parul G Patel; Monica T Yu Kimata; Julia E Biggins; Joelle M Wilson; Jason T Kimata
Journal:  J Virol       Date:  2002-07       Impact factor: 5.103

10.  Dendritic cell-mediated viral transfer to T cells is required for human immunodeficiency virus type 1 persistence in the face of rapid cell turnover.

Authors:  Suryaram Gummuluru; Vineet N KewalRamani; Michael Emerman
Journal:  J Virol       Date:  2002-11       Impact factor: 5.103

View more
  4 in total

1.  Vif substitution enables persistent infection of pig-tailed macaques by human immunodeficiency virus type 1.

Authors:  Rajesh Thippeshappa; Patricia Polacino; Monica T Yu Kimata; Edward B Siwak; David Anderson; Weiming Wang; Laura Sherwood; Reetakshi Arora; Michael Wen; Paul Zhou; Shiu-Lok Hu; Jason T Kimata
Journal:  J Virol       Date:  2011-02-02       Impact factor: 5.103

2.  Glycosyl-Phosphatidylinositol-Anchored Anti-HIV Env Single-Chain Variable Fragments Interfere with HIV-1 Env Processing and Viral Infectivity.

Authors:  Anisha Misra; Emile Gleeson; Weiming Wang; Chaobaihui Ye; Paul Zhou; Jason T Kimata
Journal:  J Virol       Date:  2018-03-14       Impact factor: 5.103

3.  Env-independent protection of intrarectal SIV challenge by vaccine induction of Gag/Vif-specific CD8+ T cells but not CD4+ T cells.

Authors:  Hiroshi Ishii; Kazutaka Terahara; Takushi Nomura; Midori Okazaki; Hiroyuki Yamamoto; Tsugumine Shu; Hiromi Sakawaki; Tomoyuki Miura; David I Watkins; Tetsuro Matano
Journal:  Mol Ther       Date:  2022-02-26       Impact factor: 12.910

4.  A variant macaque-tropic human immunodeficiency virus type 1 is resistant to alpha interferon-induced restriction in pig-tailed macaque CD4+ T cells.

Authors:  Rajesh Thippeshappa; Hongmei Ruan; Weiming Wang; Paul Zhou; Jason T Kimata
Journal:  J Virol       Date:  2013-04-03       Impact factor: 5.103

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.